Prescription drug use in U.S. fell last year
Prescription drug use in the U.S. fell last year, although total spending on drugs increased as prices rose sharply on brand-name products. Full story
Prescription drug use in the U.S. fell last year, although total spending on drugs increased as prices rose sharply on brand-name products. Full story
The Food and Drug Administration says patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its review of a controversial study. Full story
U.S. government drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer. Full story
Regulators ended last week and started this one by rejecting two potential blockbuster cholesterol drugs, leaving Wall Street wondering if tougher approval standards are here. Full story
The drugmaker Merck & Co. says its profit almost doubled in the first quarter due to a $1.4 billion distribution from a partner drug company. It sales were slightly higher. Full story
Controversy has followed a study this week that showed that the expensive combination drug Vytorin was no more effective than one of its cheaper components used alone. Full story
